Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SRGAX vs. VPMCX: which is better?

Bottom line

SRGAX vs VPMCX: the short answer

SRGAX (Stringer Tactical Adaptive Risk Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds.

Updated Nov 19, 2026

SRGAX vs VPMCX side by side

SRGAXVPMCX
TypeMutual fundMutual fund
Fund family360Vanguard
CategoryLarge BlendLarge Blend
Expense ratio—0.35%
Annual cost per $10k—$35
10-yr cost on $10k (prospectus)—$443
Max front load—0%
12b-1 fee—0%
1-yr return—+29.9%
5-yr return (annualized)—+14.3%
10-yr return (annualized)—+15.2%
Best quarter—+17.3%
Worst quarter—−20.2%
Net assets (fund)—$96.1B
Number of holdings—173
Portfolio turnover—11%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

SRGAX and VPMCX share none of their top holdings.

SRGAX top 10

    VPMCX top 10

    1. Micron Technology Inc — 13.50%
    2. Intel Corp — 6.80%
    3. Eli Lilly & Co — 6.76%
    4. KLA Corp — 3.85%
    5. Alphabet Inc — 3.52%
    6. AstraZeneca PLC — 2.35%
    7. NVIDIA Corp — 2.33%
    8. Amazon.com Inc — 2.05%
    9. Tesla Inc — 1.89%
    10. Biogen Inc — 1.88%

    FAQ

    What is the difference between SRGAX and VPMCX?
    SRGAX (Stringer Tactical Adaptive Risk Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds.
    Should I own both SRGAX and VPMCX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.